EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Leukocyte dysfunction and reduced CTLA-4 expression are associated with perianal Crohn’s disease

Murillo Duarte-Silva iD, Rogério Serafim Parra, Marley Ribeiro Feitosa, Viviani Nardini, Sandra Regina Maruyama, José Joaquim Ribeiro da Rocha, Omar Feres, Cristina Ribeiro de Barros Cardoso

Clinical and Experimental Immunology · 2024

DOI: 10.1093/cei/uxae027 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von Murillo Duarte-Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil. Hauptthemen laut MEDLINE: CTLA-4 Antigen, Crohn Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CAPES, CNPq, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although perianal Crohn’s disease (PCD) is highly associated with the exacerbated inflammation, the molecular basis and immunological signature that distinguish patients who present a history of perianal lesions are still unclear. This paper aims to define immunological characteristics related to PCD. In this cross-sectional observational study, we enrolled 20 healthy controls and 39 CD patients. Blood samples were obtained for the detection of plasma cytokines and lipopolysaccharides (LPS). Peripheral blood mononuclear cells (PBMCs) were phenotyped by flow cytometry. Leukocytes were stimulated with LPS or anti-CD3/anti-CD28 antibodies. Our results show that CD patients had augmented plasma interleukin (IL)-6 and LPS. However, their PBMC was characterized by decreased IL-6 production, while patients with a history of PCD produced higher IL-6, IL-8, and interferon-γ, along with decreased tumor necrosis factor alpha (TNF). CD patients had augmented FoxP3 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulatory markers, though the PCD subjects presented a significant reduction in CTLA-4 expression. CTLA-4 as well as IL-6 and TNF responses were able to distinguish the PCD patients from those who did not present perianal complications. In conclusion, IL-6, TNF, and CTLA-4 exhibit a distinct expression pattern in CD patients with a history of PCD, regardless of disease activity. These findings clarify some mechanisms involved in the development of the perianal manifestations and may have a great impact on the disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CTLA-4 AntigenCrohn DiseaseHumansMaleFemaleAdultCross-Sectional StudiesMiddle AgedLeukocytes, MononuclearInterleukin-6LipopolysaccharidesCytokinesTumor Necrosis Factor-alphaForkhead Transcription Factors

Stichwörter der Autor:innen

CTLA-4Crohn’s diseaseinflammatory bowel diseaseinterleukin-6perianal disease

Substanzen

CTLA-4 AntigenCTLA4 protein, humanInterleukin-6LipopolysaccharidesCytokinesTumor Necrosis Factor-alphaForkhead Transcription FactorsFOXP3 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
  • Department of Clinical Analysis, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
  • Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
  • Department of Genetics and Evolution, Federal University of São Carlos, São Carlos, SP, Brazil.

ORCID-Profile: Murillo Duarte-Silva

Förderung

  • CAPES
  • CNPq
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Duarte-Silva, M., Parra, R. S., Feitosa, M. R., Nardini, V., Maruyama, S. R., da Rocha, J. J. R., Feres, O., & de Barros Cardoso, C. R. (2024). Leukocyte dysfunction and reduced CTLA-4 expression are associated with perianal Crohn’s disease. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxae027

Vancouver

Duarte-Silva M, Parra RS, Feitosa MR, Nardini V, Maruyama SR, da Rocha JJR, et al. Leukocyte dysfunction and reduced CTLA-4 expression are associated with perianal Crohn’s disease. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxae027

BibTeX
@article{DuarteSilva2024,
  author = {Duarte-Silva, Murillo and Parra, Rogério Serafim and Feitosa, Marley Ribeiro and Nardini, Viviani and Maruyama, Sandra Regina and da Rocha, José Joaquim Ribeiro and Feres, Omar and de Barros Cardoso, Cristina Ribeiro},
  title = {Leukocyte dysfunction and reduced CTLA-4 expression are associated with perianal Crohn’s disease},
  journal = {Clinical and Experimental Immunology},
  year = {2024},
  doi = {10.1093/cei/uxae027}
}
Kostenlos starten →